BUZZ-ADMA Biologics slips after short‑seller Culper Research alleges inflated sales
ADMA Biologics, Inc.
ADMA Biologics, Inc. ADMA | 0.00 |
** Shares of ADMA Biologics ADMA.O fall 7.7% to $12.55
** Culper Research says it is short on ADMA
** Culper accuses the company of inflating its sales figures by pushing excess inventory onto distributors
** Culper estimates that ADMA's revenues fell 3% in 2025, not the 20% growth the company reported for the year
** ADMA did not immediately respond to a Reuters request for comment
** Including session's moves, stock down 30.9% YTD
